StemCells, Inc. Reports First Quarter Financial Results and Announces Reduction in Force
04 mai 2011 16h01 HE
|
StemCells, Inc.
PALO ALTO, Calif., May 4, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Announces Webcast to Discuss First Quarter Financial Results and Business Update
02 mai 2011 09h03 HE
|
StemCells, Inc.
PALO ALTO, Calif., May 2, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Advances Alzheimer's Disease Program Through Collaboration With Leading Researcher
18 avr. 2011 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., April 18, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that it has entered into a collaboration with Frank LaFerla, Ph.D., a world renowned leader in...
StemCells, Inc. Discontinues Batten Disease Program
08 avr. 2011 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., April 8, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that it has discontinued its Phase Ib clinical trial in neuronal ceroid lipofuscinosis (NCL, also...
StemCells, Inc. Adds Serum-Free and Animal Component-Free Cell Culture Supplements to Its SC Proven(R) Product Portfolio
29 mars 2011 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., March 29, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today the launch of three new cell culture supplements for the derivation, culture and differentiation of...
StemCells, Inc. Further Expands SC Proven(R) Product Portfolio With New Line of Purified Whole Cell Lysate Reagents
22 mars 2011 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., March 22, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today the launch of nine new products and three related kits to facilitate stem cell research. The...
StemCells, Inc. Initiates World's First Neural Stem Cell Trial in Spinal Cord Injury
14 mars 2011 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., March 14, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today the initiation of a Phase I/II clinical trial of its proprietary HuCNS-SC® human neural stem...
StemCells, Inc. Reports Fourth Quarter and Fiscal 2010 Financial Results and Business Highlights
11 mars 2011 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., March 11, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. to Present at ROTH Capital Partners Growth Conference
08 mars 2011 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., March 8, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Chief Financial Officer Rodney Young will present an update on the Company's programs and...
StemCells, Inc. to Present at New York Stem Cell Summit
23 févr. 2011 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., Feb. 23, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Martin McGlynn, President and CEO, and Stephen Huhn, M.D., Vice President and Head of CNS...